Oropharyngeal cancer

There are 25 papers on oropharyngeal cancer in aging research: 1 trial and 15 observational studies in people, 7 reviews.

Disease

25 papers study it14 more mention it8 findings

2 new papers in 30 daysSee all 39 papers on oropharyngeal cancer

“Taking more than 1 multivitamin daily was also strongly positively associated with the risk of oropharyngeal cancer in women (HR, 1.53, 95% CI: 1.04-2.24; P-trend < 0.0001).”
Multivitamin Use and Overall and Site-Specific Cancer Risks in the National Institutes of Health-AARP Diet and Health StudyThe Journal of nutrition2022doi:10.1093/jn/nxab322
  • Human trial1
  • Humans15
  • In silico2

Upstream

1

Telomere length

no changein silico1OR 0.999

1 study
  1. Telomere length showed no clear effect on oropharyngeal cancer in silico (OR = 0.999, 95% CI 0.998-1.001, P = .650).

    In silico

More on Telomere length

Associations

7

Wildfire-specific particulate matter 2.5

upin humans1

1 study
  1. Wildfire-specific particulate matter 2.5 is associated with oropharyngeal cancer in humans (cRR 1.09 (95% CI 1.06–1.13)).

    Humansoropharynx

More on Wildfire-specific particulate matter 2.5

OPC risk prediction models

upin silico1

1 study
  1. OPC risk prediction models predict oropharyngeal cancer in internal validation.

    In silicoin internal validation

Human papillomavirus infection

upin humans1

1 study
  1. Human papillomavirus infection is linked with a higher risk of oropharyngeal cancer in humans (AAPC 9.65% (95% CI: 5.81-13.62)).

    Humansmales

More on Human papillomavirus infection

HPV16-E6 antibodies

upin humans1

1 study
  1. HPV16-E6 antibodies predict oropharyngeal cancer in humans (meta-analysis of HPV-OPC detection) (sensitivity 83.1%, specificity 94.6%).

    Reviewmeta-analysis of HPV-OPC detection

More on HPV16-E6 antibodies

Inflammatory tongue condition

upin humans1OR 1.3

1 study
  1. Inflammatory tongue condition is linked with a higher risk of oropharyngeal cancer in humans (preceding cancer/control selection by >12 months) (OR 1.3, 95% CI 1.0-1.6).

    Humanspreceding cancer/control selection by >12 months

More on Inflammatory tongue condition

Multivitamin

upin humans1HR 1.53

1 study
  1. Multivitamin is linked with a higher risk of oropharyngeal cancer in humans (HR 1.53, 95% CI: 1.04-2.24).

    Humans>1 dailyfemalesn = 489,640

More on Multivitamin

Human papillomavirus vaccine

downin silico1

1 study
  1. Human papillomavirus vaccine lowers the risk of oropharyngeal cancer in silico (by 2045) (48.1% men, 42.5% women (36-45); 9.0% men, 22.6% women (46-55)).

    In silicoby 2045

More on Human papillomavirus vaccine

Trial sponsors

Funding

10 grants since 2017

National Institute of Dental and Craniofacial Research$9.6MNational Cancer Institute$431KBaylor College of Medicine$177K

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 2Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 2Sep 2026: 4Oct 2026: 6Nov 2026: 016 papers in 12 months

See all 39 papers on oropharyngeal cancer